Zhenru Wu
Papers
2
Total Citations
57
H-Index
2
About
Dr. Zhenru Wu is a leading surgical oncologist specializing in the management of hepatobiliary malignancies, with a particular focus on hilar cholangiocarcinoma (HCCA) and gallbladder carcinoma (GBC). His research critically evaluates the evolving role of minimally invasive surgery (MIS) in these complex, high-risk cancers. Dr. Wu’s major contributions include defining the strict patient selection criteria and technical limitations of MIS for HCCA, a tumor notorious for its aggressive local invasion into vasculature and liver parenchyma. His seminal 2018 review on this topic, cited 39 times, serves as a foundational reference for surgeons navigating the delicate balance between radical resection and minimally invasive approaches. Similarly, his 2020 analysis of MIS in gallbladder carcinoma, with 18 citations, systematically outlines the challenges posed by GBC’s propensity for early lymph node metastasis, providing a critical framework for safe surgical decision-making. Through these works, Dr. Wu has helped delineate the current state-of-the-art and future directions for MIS in biliary tract cancers, directly guiding clinical practice and inspiring further innovation in this technically demanding field.
Research Focus
Key Achievements
Top Papers
- 1
- 2